Organigram Global Inc (OGI) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to 0 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Organigram Global Inc   (NASDAQ: OGI)

Organigram Global Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Organigram Global Inc in the third quarter 2026?
Organigram Global Inc achieved a return on average equity (ROE) of 19.82 % in its third quarter 2026, this is above OGI's average return on equity of -16.86%.
Organigram Global Inc shareholder's equity over the 12 months ending in its third quarter 2026 are valued at $286 million

ROE has advanced compared to -9.05% in the second quarter 2026, due to net income growth.

Within the Major Pharmaceutical Preparations industry 69 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from to 2645.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Sep 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter
Y / Y Equity Change 27.75 % -0.36 % 14.1 % 18.09 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 57 -24 6 -10 -14
Return On Equity (TTM) 19.82 % -9.05 % 2.27 % -3.77 % -5.52 %
OGI's Total Ranking # 2645 # # # # 2864
Equity (TTM) in Millions 342 266 267 267 267
Seq. Equity Change 28.21 % -0.36 % 0 % 0 % 0 %
Seq. Net Income Change - - - - -

Back to OGI Management Effectiveness >> OGI's 5 Years Annual ROE >> Compare OGI ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 70
Sector # 217
Overall # 2645

Return On Equity Statistics
High Average Low
-2.89 %
-16.86 %
-44.05 %
(Aug 31 2022)   (Aug 31 2020)





OGI Annual Return On Equity (Sep 30 2025)
2025		 (Sep 30 2024)
2024		 (Sep 30 2023)
2023		 (Aug 31 2022)
2022		 (Aug 31 2021)
2021
Total Equity in Millions 267 226 208 388 380
Y / Y Equity Change 18.09 % 8.85 % -46.39 % 2.15 % 65.32 %
Net Income in Millions -19 -33 -11 -11 -103
Y / Y Net Income Change - - - - -
Return On Equity -7.09 % -14.75 % -5.26 % -2.89 % -27.14 %

Back to OGI Management Effectiveness >> OGI's 5 Years Annual ROE >> Compare OGI ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
OGI's' Return on Equity at Yahoo Finance
OGI's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for OGI's Competitors
Subscribers only: Roe for Organigram Global Inc 's Suppliers
Subscribers only: Return On Equity for OGI's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Vaxart Inc   53.04 %
Qhslab Inc   51.21 %
Tenet Healthcare Corp  50.64 %
Nrc Health  48.29 %
Concentra Group Holdings Parent Inc   48.13 %
Bristol myers Squibb Company  46.65 %
Agilent Technologies inc   41.99 %
Eton Pharmaceuticals Inc   40.13 %
Adma Biologics Inc   39.59 %
Dexcom Inc   36.25 %
Transmedics Group Inc   33.37 %
Arcutis Biotherapeutics Inc   32.92 %
Caredx Inc   32.81 %
Zevra Therapeutics Inc   32.56 %
Acadia Pharmaceuticals Inc   32.39 %
Pro dex Inc   31.96 %
Protalix Biotherapeutics inc   31.61 %
Illumina Inc   31.08 %
Innoviva Inc   30.03 %
Phibro Animal Health Corporation  29.66 %
Chemed Corporation  29.45 %
Solventum Corporation  28.96 %
Pacs Group Inc   27.00 %
Sotera Health Company  26.75 %
Insulet Corporation  26.69 %
Bioventus Inc   25.96 %
Johnson and Johnson  25.74 %
Encompass Health Corporation  25.52 %
Resmed Inc   24.21 %
Healthcare Services Group Inc   24.12 %

Date modified: 2026-10-15T05:23:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.